Boehringer Ingelheim Corporation
Boehringer Ingelheim Corporation, a leading global pharmaceutical company, is headquartered in the United States and operates extensively across Europe, Asia, and other regions. Founded in 1885, the company has established itself as a key player in the pharmaceutical and animal health industries, focusing on innovative research and development. Boehringer Ingelheim is renowned for its core products, which include prescription medications, vaccines, and animal health solutions. Their commitment to advancing healthcare through unique therapeutic approaches sets them apart in a competitive market. With a strong emphasis on human and veterinary medicine, the company has achieved notable milestones, including significant advancements in respiratory and cardiovascular treatments. As a prominent entity in the pharmaceutical landscape, Boehringer Ingelheim continues to enhance its market position through a dedication to innovation and sustainability, making a lasting impact on global health.
DitchCarbon Score
How does Boehringer Ingelheim Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Boehringer Ingelheim Corporation's score of 23 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Boehringer Ingelheim Corporation's reported carbon emissions
Boehringer Ingelheim Corporation, headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. As a current subsidiary, it inherits its climate commitments and emissions data from its parent organisation, Boehringer Ingelheim GmbH. While there are no documented reduction targets or specific emissions figures, the company is part of a broader corporate family that is likely engaged in various sustainability initiatives. However, details regarding specific reduction initiatives or targets, such as those from the Science Based Targets initiative (SBTi), are not provided. Boehringer Ingelheim Corporation's commitment to addressing climate change is evident through its participation in industry-standard initiatives, although specific metrics and achievements remain unspecified. The absence of detailed emissions data highlights the need for transparency and accountability in corporate climate strategies.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Boehringer Ingelheim Corporation is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
